MSH2 and adenoma: As seen in Fig. 3, there were no differences in the cumulative incidences of CRC by gene in path_MLH1, path_MSH2 and path_MSH6 carriers stratified by the presence or absence of adenomas (the curves are overlapping and no confidence estimates or calculation of p-values were needed to reach this conclusion).